MiniMed 780G System for Type 1 Diabetes

"This research project has a range for enrollment, stipulating that participants must be older than 7 but younger than 80 to qualify."

"Currently, the trial is recruiting from 15 different sites such as Alberta Children's Hospital Research Institute in Calgary, Valley Research in Fresno and Barbara Davis Center for Diabetes in Aurora. An additional dozen medical centres are also included."

"To carry out the study, 250 suitable candidates must be identified and enrolled. Medtronic Diabetes is organizing this trial from multiple sites including Alberta Children's Hospital Research Institute in Calgary and Valley Research in Fresno, California."

"This clinical trial is currently accepting 250 participants with a diagnosis of type 1 diabetes, between the ages of two and eighty. To be eligible for enrolment, individuals must meet certain conditions, such as having a minimum daily insulin requirement (Total Daily Dose) above 8 units; being literate in one of the languages offered by the pump system; and consenting to fingerstick blood glucose measurements when necessary. Furthermore, those aged fourteen to eighty are required to have had their medical condition diagnosed at least two years prior, while minors aged seven through thirteen need only demonstrate that they have lived with type 1 diabetes since before turning seven. Finally, any"

"Per the information provided on clinicaltrials.gov, this is an ongoing trial with a start date of March 17th 2022 and its most recent update occurring on October 26th 2022."

"Within the 3 month trial period, the primary safety outcome to be assessed is a change in HbA1c. Secondary endpoints include evaluating mean percent of time in range (TIR 70-180 mg/dL [3.9 -10.0 mmol/L]) and hypoglycemia (< 54 mg/dL [3.0 mmol/L]), for both age 7-17 and 18-80 groups respectively, with tests assessing superiority or noninferiority as appropriate."